Abstract
Accepted 10 September 1996
The response to the bisphophosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia in the same child. The bisphosphonates may have other roles in osteogenesis imperfecta by decreasing bone turnover.
Full Text
The Full Text of this article is available as a PDF (46.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boonekamp P. M., van der Wee-Pals L. J., van Wijk-van Lennep M. M., Thesing C. W., Bijvoet O. L. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner. 1986 Feb;1(1):27–39. [PubMed] [Google Scholar]
- Chines A., Petersen D. J., Schranck F. W., Whyte M. P. Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr. 1991 Jul;119(1 Pt 1):51–57. doi: 10.1016/s0022-3476(05)81038-8. [DOI] [PubMed] [Google Scholar]
- Huaux J. P., Lokietek W. Is APD a promising drug in the treatment of severe osteogenesis imperfecta? J Pediatr Orthop. 1988 Jan-Feb;8(1):71–72. doi: 10.1097/01241398-198801000-00017. [DOI] [PubMed] [Google Scholar]
- Sillence D. O., Senn A., Danks D. M. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979 Apr;16(2):101–116. doi: 10.1136/jmg.16.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vetter U., Maierhofer B., Müller M., Lang D., Teller W. M., Brenner R., Frohneberg D., Wörsdörfer O. Osteogenesis imperfecta in childhood: cardiac and renal manifestations. Eur J Pediatr. 1989 Dec;149(3):184–187. doi: 10.1007/BF01958277. [DOI] [PubMed] [Google Scholar]